Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Real Estate
  • Entertainment
  • Software
  • Information Technology
  • Business
Washingtoner

Ovarian Cancer Research Alliance Joins with Rivkin Center for Ovarian Cancer Research, Strengthening the Fight Against Ovarian Cancer
Washingtoner/10281298

Trending...
  • "Warrior Defined" Event Brings Men Together in Charlotte, With Calls for Events Across the U.S
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
  • Massage Revolution Expands to Santa Monica With New Wilshire Boulevard Location
NEW YORK, Jan. 28, 2025 ~ The Ovarian Cancer Research Alliance (OCRA), the world's largest gynecologic cancer nonprofit, has announced a significant collaboration with the Rivkin Center for Ovarian Cancer Research, effective April 1, 2025. This partnership brings together two highly respected organizations with a shared goal of advancing research for a cure for ovarian cancer.

OCRA will be building upon the Rivkin Center's impressive legacy of funding innovative ovarian cancer research and providing crucial resources to the Pacific Northwest community. This integration will also allow OCRA to expand its reach nationally and globally, ensuring that education, support, and scientific advancements are accessible to the entire ovarian cancer community.

Audra Moran, President and CEO of OCRA, expressed her admiration for the Rivkin Center's contributions in advancing ovarian cancer research and connecting with the community. She believes that this collaboration will create a stronger foundation to support patients and families while honoring Dr. Saul Rivkin's remarkable legacy and driving progress in research.

More on Washingtoner
  • NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
  • The Human Resilience Project Embarks Upon Paraguay Expedition
  • Georgia's Magical Nights of Lights Bigger and Brighter for 2026
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event

This announcement comes just one month after The Clearity Foundation joined forces with OCRA, making it the largest organization dedicated to fighting gynecologic cancers in the world. Moran sees these partnerships as a significant step forward in their mission to accelerate research, improve patient care, and create a more cohesive network for those affected by ovarian cancer.

Since its establishment in 1996, the Rivkin Center has been at the forefront of ovarian cancer research. It has provided essential seed-funding grants that have led to groundbreaking discoveries and hosted the biennial Ovarian Cancer Research Symposium in partnership with the American Association of Cancer Research (AACR). Under OCRA's leadership, these signature programs will continue with grants and symposiums renamed to honor Dr. Rivkin's enduring contributions to the field.

Dr. Saul Rivkin, retired oncologist and founder of the Rivkin Center, expressed his confidence in OCRA as an aligned partner to carry forward their vision and amplify their efforts. He believes that this partnership will ensure the growth and success of their investments in research and relationships with the community, bringing them closer to a cure. Dr. Rivkin and his family fully support this exciting new chapter.

More on Washingtoner
  • OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
  • Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach
  • "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME
  • Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month
  • Indianapolis Criminal Defense Firm Rigney Law LLC Relaunches Criminal Law Podcast "Tales from the Brown Desk"

Melissa Rivkin, current board president of the Rivkin Center, will join OCRA's Board of Directors, while Dr. Jackie Lang, director of Scientific Programs at the Rivkin Center, will play a crucial role in OCRA's engagement with the scientific community.

OCRA is committed to continuing beloved Rivkin Center initiatives such as the annual SummeRun for Ovarian Cancer, which will take place on July 13, 2025, in Seattle. Dr. Rivkin will be present at the finish line as always.

More details about the combined programs and services will be shared in the coming months. Both OCRA and the Rivkin Center are dedicated to ensuring a seamless transition that honors the legacy of the Rivkin Center while strengthening support for patients, researchers, and the broader ovarian cancer community.
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • A Sky Lites Drone Show welcomes new students University of Oregon
  • CinderLabs AIRA Governs NVIDIA's Open Agent Safety Platform, Turning Enforcement Into Evidence
  • Tacoma: Officer Involved Shooting – 700 Block of South Stevens Street
  • Names Are Not Important Asks What Remains When Identity Is Stripped of Labels
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
  • Virtually Tour Heritage at South Brunswick's Resort-Style Living - Experience Indoor and Outdoor Amenities at Your Fingertips
  • Derek Cook's Roofing Encourages Homeowners to Prepare for Fall Weather
  • Boston Industrial Solutions Expands Product Offering with Pad Printing Pads and Silicone for Custom Pad Manufacturing
  • Rodeo FX Originals Appoints Yvann Thibaudeau Head of Development & IP
  • Phoenix 5/7 Emerges as a Genre-Fluid Artist Collective
  • Massage Revolution Expands to Santa Monica With New Wilshire Boulevard Location
  • "Warrior Defined" Event Brings Men Together in Charlotte, With Calls for Events Across the U.S
  • Dr. Constance Scharff Returns PNW Chapter Flag, Shares Iñupiat Findings at Explorers Club Dinner
  • Dion Abadi Publishes Free Collector Tips Hub for Art and Jewelry Buyers
  • Spokane: Washington Street to Close for Grind & Overlay Project
  • Spokane: Camp Sekani Update 09/25/26
  • World-Renowned Body Language Expert Mark Bowden Headlines INSPIRE Northwest 2026 in Wenatchee, WA
  • Tacoma Arts Month Celebrates 25 Years This October
  • ASN Software Introduces New California CARS Act Dealer Updates
  • USA Air Management Marks 30 Years of Air Duct Cleaning in NJ Urges Homeowners to Schedule Dryer Vent Cleaning Before Heating Season
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: Police Arrest Registered Sex Offender for Child Sexual Abuse Material - 117
  • Continuous You Foundation Announces Partnership with Haawke Neural Technology - 101
  • Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
  • Tacoma: Applicants Sought for the Board of Ethics
  • King Larry Steps Into His Moment With Music, Major Performances and a Story Built on Persistence
  • Tacoma: Applicants Sought for the Audit Advisory Board
  • ChargeOn Announces Conversational Payment Management Solution
  • Applicants Sought for the Tacoma Arts Commission and the Tacoma Creates Advisory Board
  • Labor Day Observed by City of Tacoma on September 7
  • South Tacoma Glass Recycling Drop-Off Location Closing

Similar on Washingtoner

  • NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
  • Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute